Erudio Healtherudio.com
Clinical trial · no report yet · Phase 1/Phase 2
DUART
Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
- NCT02891161 ↗
- Terminated
- Monika Joshi, MD
- Deep
We haven't built an HCP commentary report on DUART (durvalumab plus radiation therapy in localized urothelial cancer of bladder) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on DUART so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 29 | |
| YouTube | 1 |
The trial
ClinicalTrials.gov- Official title
- Phase Ib/II Study of Concurrent Durvalumab And Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder: Big Ten Cancer Research Consortium BTCRC-GU15-023
- Phase
- Phase 1/Phase 2
- Status
- Terminated
- Conditions
- Urothelial Cancer
- Interventions
- durvalumab; Radiation Therapy
- Arms
- Arm A: Safety Run In Phase Ib · Experimental
- Arm B: Investigational Treatment Phase II · Experimental
- Enrollment
- 26
- Primary outcomes
- Phase Ib: Safety Assessment - Evaluation of DLT (Dose Limiting Toxicity) Rate
- All Phases: Progression Free Survival Rate at 1 Year
- Phase II: Disease Control Rate to Concurrent durvaRT Followed by Durvalumab
- Sponsor
- Monika Joshi, MD with AstraZeneca
- Start
- Nov 16, 2016
- Primary completion
- Aug 6, 2019
- Results posted
- Yes
- Registry record
- NCT02891161 · updated Nov 27, 2024
Publications
linked from the registry- Joshi M, Tuanquin L, Zhu J, Walter V, Schell T, Kaag M, Kilari D, Liao J, Holder SL, Emamekhoo H, Sankin A, Merrill S, Zheng H, Warrick J, Hauke R, Gartrel B, Stein M, Drabick J, Degraff DJ, Zakharia Y. Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023. J Immunother Cancer. 2023 Feb;11(2):e006551. doi: 10.1136/jitc-2022-006551. PubMed 36822667